Edwards Lifesciences (EW): Sen. Markwayne Mullin disclosed a purchase $1K–$15K
Sen. Markwayne Mullin disclosed a purchase of Edwards Lifesciences in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 29 days
- Disclosure lag
- Traded
- Oct 3, 2023
- Disclosed
- Nov 1, 2023
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 21, 2023CongressDisclosed purchase of EW — reported range $1,001 - $15,000
- Sep 7, 2023FDARecall: Fogarty Thru-Lumen Embolectomy Catheter, REF: 12TLW805F35
- Sep 13, 2023CongressDisclosed purchase of EW — reported range $15,001 - $50,000
- Oct 3, 2023 · this disclosureCongressDisclosed purchase of EW — reported range $1,001 - $15,000
What came next
- Oct 4, 2023FDARecall: Acumen IQ Sensor with VAMP System, REFs: AIQS6AZ & AIQS6AZ5, STERILEEO, Rx only. For use in intravascular pressure monitoring.
- Oct 4, 2023FDARecall: TruWave Pressure monitoring set, REF: PX212: cc/12 in (30cm), PX260: (3 cc/60in (150cm), PX272: 3 cc/72in (180cm), PX284: 3 cc/84 in (210 cm), PX2X2: x2 (3cc),…
- Oct 4, 2023FDARecall: FloTrac Sensor, REF: MHD8 & MHD85,MHD6R5, MHD8R, MHD8R5, MHD8S, STERILEEO, Rx only. For use in intravascular pressure monitoring.
- Oct 4, 2023FDARecall: TruWave with Vamp System Pressure monitoring set, REF: PXAVMP(3cc)/VAMP 68 in (173cm) PXAVMP3: x3 (3cc)/VAMP PXVK0364:(3cc)/VAMP 96in (241cm); PXVK0853: x3 (3c…
- Oct 4, 2023FDARecall: FloTrac Sensor with Vamp System, REF: MHD6AZ, MHD6AZ5 , MHD6C502 STIRLEEO, Rx only. For use in intravascular pressure monitoring.
- Oct 4, 2023FDARecall: Acumen IQ Sensor, REFs: AIQS6, AIQS65, AIQS6R, AIQS6R5, AIQS8, AIQS85, AIQS8R5, Rx only, Sterile EO. For use in intravascular pressure monitoring.
- Oct 24, 2023FDAFDA device clearance: Acumen IQ finger cuff
- Oct 31, 2023FDAFDA device clearance: HemoSphere Alta Advanced Monitoring Platform; HemoSphere Alta Advanced Monitor (Smart Recovery); HemoSphere Alta Advanced Monitor (Cardiac); HemoSphere Alta…
- Nov 17, 2023FDAFDA device clearance: Edwards Algorithm for Measurement of Blood Hemoglobin
- Dec 4, 2023CongressDisclosed sale of EW — reported range $1,001 - $15,000
- Dec 11, 2023CongressDisclosed purchase of EW — reported range $1,001 - $15,000
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Edwards Lifesciences
For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.
Other recent filings by Sen. Markwayne Mullin
- Senate eFD periodic transaction report at UnitedHealth (UNH)Mar 10, 2026
- Senate eFD periodic transaction report at AutoZone (AZO)Mar 10, 2026
- Senate eFD periodic transaction report at Intuit (INTU)Mar 10, 2026
- Senate eFD periodic transaction report at Monolithic Power Systems (MPWR)Mar 2, 2026
- Senate eFD periodic transaction report at McKesson Corporation (MCK)Mar 2, 2026
The full history of Sen. Markwayne Mullin is on the profile page.
How this filing works
Explore the data
Other disclosures at Edwards Lifesciences
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its EW page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
